Pegylated OXM variants
    1.
    发明授权

    公开(公告)号:US10537646B2

    公开(公告)日:2020-01-21

    申请号:US14405597

    申请日:2013-06-04

    摘要: A composition which includes oxyntomodulin and polyethylene glycol polymer (PEG polymer) linked via a reversible linker such as 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) is disclosed. Pharmaceutical compositions comprising the reverse pegylated oxyntomodulin and methods of using same are also disclosed.

    LONG-ACTING OXYNTOMODULIN VARIANTS AND METHODS OF PRODUCING SAME
    8.
    发明申请
    LONG-ACTING OXYNTOMODULIN VARIANTS AND METHODS OF PRODUCING SAME 有权
    长效氧自由基变异体及其生产方法

    公开(公告)号:US20150072924A1

    公开(公告)日:2015-03-12

    申请号:US14395441

    申请日:2013-04-17

    IPC分类号: C07K14/575 C07K14/59

    摘要: This invention is directed to a chorionic gonadotrophin carboxy terminal peptide (CTP) modified dual GLP-1/Glucagon receptor agonist, and methods of producing and using the same. In one embodiment, the present invention provides a CTP-modified polypeptide comprising a dual GLP-1/Glucagon receptor agonist and at least one chorionic gonadotrophin carboxy terminal peptide (CTP) attached to the amino terminus or carboxy terminus of said agonist.

    摘要翻译: 本发明涉及绒毛膜促性腺激素羧基末端肽(CTP)修饰的双重GLP-1 /胰高血糖素受体激动剂及其制备和使用方法。 在一个实施方案中,本发明提供了包含双GLP-1 /胰高血糖素受体激动剂和连接于所述激动剂的氨基末端或羧基末端的至少一个绒毛膜促性腺激素羧基末端肽(CTP)的CTP-修饰的多肽。